carbostyril has been researched along with Chronic Kidney Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, J; Chinta, VR; Gang, S; Gupta, U; Jeloka, T; Kanani, P; Kansagra, K; Khetan, P; Mavani, S; Rajanna, S; Reddy, SVK; Ruhela, V; Varade, D; Zala, K | 1 |
| Agrawal, D; Bandara Galahitiyawa, MC; De Silva, S; Jikki, P; Kanani, P; Kansagra, K; Koradia, P; Krishnan, J; Mavani, SB; Nazar, A; Parmar, D; Rajanna, S; Ramakrishna, C; Ruhela, V; Shah, H; Sharma, N; Shukla, V; Varade, D; Zala, K | 1 |
| Dhillon, S | 1 |
| Joshi, SN; Kansagra, KA; Nakrani, VB; Parmar, DV; Patel, HV; Patel, JC; Patel, NB; Shaikh, FA; Sharma, NS; Shelat, AD | 1 |
| Jones, R; Levy, JB; Milburn, J | 1 |
2 review(s) available for carbostyril and Chronic Kidney Diseases
| Article | Year |
|---|---|
Desidustat: First Approval.
Topics: Adult; Anemia; Antineoplastic Agents; COVID-19 Drug Treatment; Erythropoietin; Humans; Hypoxia; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Quinolones; Renal Insufficiency, Chronic | 2022 |
Renal effects of novel antiretroviral drugs.
Topics: Adenine; Alanine; Anti-HIV Agents; Atazanavir Sulfate; Cobicistat; Creatinine; Disease Progression; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Oxazines; Piperazines; Proteinuria; Pyridones; Quinolones; Raltegravir Potassium; Renal Insufficiency, Chronic; Tenofovir | 2017 |
3 trial(s) available for carbostyril and Chronic Kidney Diseases
| Article | Year |
|---|---|
Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D).
Topics: Anemia; Epoetin Alfa; Erythropoietin; Hematinics; Hemoglobins; Humans; Quinolones; Recombinant Proteins; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND).
Topics: Anemia; Darbepoetin alfa; Erythropoietin; Hematinics; Hemoglobins; Hepcidins; Humans; Quinolones; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Endothelial Growth Factor A | 2022 |
Outcomes of Desidustat Treatment in People with Anemia and Chronic Kidney Disease: A Phase 2 Study.
Topics: Administration, Oral; Adult; Anemia; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erythropoiesis; Female; Hemoglobins; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases; Male; Middle Aged; Quinolones; Renal Insufficiency, Chronic; Treatment Outcome | 2019 |